Seasoned electrophysiology commercial leader joins the Company to expand operating capabilities Westport, CT, March 16, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]
Financial
Avive Secures $22 Million in Series A Funding to Advance Intelligent AED and Lifesaving Platform for Out-of-Hospital Cardiac Arrest
Deployment of a Novel 4-Minute City Program that Engages Community Members to Speed AED Response Time, Improve Survival Rates and Focus on Overcoming Socioeconomic Disparities in Healthcare SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Avive Solutions, Inc., developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, today […]
Circle Cardiovascular Imaging Announces Strategic Growth Investment from Thoma Bravo
Investment to drive future growth and innovation and strengthen market leadership position CALGARY, AB and SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Circle Cardiovascular Imaging Inc. (“Circle CVI”), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo’s partnership is expected […]
Hyloris reports results for the full year 2021
Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant expansion of commercial footprint of Maxigesic® IV Tranexamic RTU licensing extended beyond U.S. €50 million in cash and cash equivalents to execute ambitious growth strategy LIÈGE, Belgium, March […]
Mineralys Therapeutics Appoints Adam Levy as Chief Financial Officer and Chief Business Officer
PHILADELPHIA, March 15, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension, today announced the appointment of Adam Levy as the company’s new Chief Financial Officer (CFO) and Chief Business Officer (CBO). “We are pleased to announce Adam’s appointment and welcome […]
Semler Scientific’s Board of Directors authorizes an up to $20.0 million stock repurchase program
SANTA CLARA, Calif., March 14, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock repurchase program. Semler Scientific may purchase shares on a discretionary basis from time […]
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
Topline data from Phase 2b ASPEN-COVID-19 clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the last week of March 2022 WESTMINSTER, Colo., March 14, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular […]
The Vascular Care Group Welcomes Nationally Recognized Vein Expert Dr. Harold J. Welch
Decorated physician brings 30+ years of experience to patients on Cape Cod HYANNIS, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Harold J. Welch, MD, FACS, RVT, RPVI has recently joined the Hyannis, […]
iRhythm® Technologies Announces Kevin King to Retire from Board of Directors
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022. Mr. King joined the iRhythm Board in […]
NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study […]



